Clinical trial
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With…
NCT00471237 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00471237 |
|---|---|
| Title | A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis. |
| Official title | Study CR9108963: A 12-month, Randomized, Double-blind, Parallel-group, Placebo and Active-controlled Dose-range Finding Study of the Efficacy and Safety of SB-751689 in Post-menopausal Women With Osteoporosis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Ronacaleret, Teriparatide, Alendronate |
| Enrollment | 564 |
| Start date | May 14, 2007 |
| Primary completion | Dec 26, 2008 |
| Completion | Dec 26, 2008 |
| First posted | May 9, 2007 |
| Last update posted | Nov 7, 2017 |
| Countries | Argentina, Australia, Belgium, Denmark, Germany, Hong Kong, Mexico, Norway, Poland, Russia, South Africa, South Korea and 2 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: